← Back

Dr. Reddy’s Laboratories Ltd ADR

Dr. Reddy's Laboratories Limited is an integrated pharmaceutical company operating in North America, Europe, India, Russia, and internationally. It has three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment makes and markets prescription and over-the-counter finished pharmaceutical products, including branded and generic formulations, and also engages in biologics. The PSAI segment produces active pharmaceutical ingredients and intermediates, offers contract research services, and manufactures steroids. The Others segment develops therapies in oncology and inflammation and works on differentiated formulations. The company's products cover therapeutic areas such as gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, nephrology, vaccines, vitamins and minerals, and pain management. Incorporated in 1984, it is headquartered in Hyderabad, India.

Country
Price · split & dividend adjusted
News & notes moving RDY